NCT00457288View on ClinicalTrials.gov

Efficacy and Safety of TF002 in Cutaneous Mastocytosis

PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

April 30, 2007

Study Completion Date

September 30, 2007

Conditions
Cutaneous Mastocytosis
Interventions
DRUG

TF 002

Trial Locations (4)

D-50924

Klinik und Poliklinik für Dermatologie und Venerologie der Universität, Cologne

D-55131

Universitäts-Hautklinik, Mainz

D-80337

Klinik und Poliklinik für Dermatologie und Allergologie der LMU, München

D-80802

Klinik und Poliklinik für Dermatologie und Allergologie am Biederstein der TU, München

Sponsors
All Listed Sponsors
lead

JADO Technologies GmbH

INDUSTRY

NCT00457288 - Efficacy and Safety of TF002 in Cutaneous Mastocytosis | Biotech Hunter | Biotech Hunter